Holdings
Nan Fung Group Holdings Ltd
As of Sep 30, 2026, Nan Fung Group Holdings Ltd reported 25 positions worth US$139M. Largest: LB Pharmaceuticals Inc, MapLight Therapeutics, Inc. and Obsidian Therapeutics, Inc. What it bought and sold, with each filing.
Holdings
- Positions
- 25
- Value as reported
- US$139M
- Holdings as of
- Sep 30, 2026
- Last filed
- Nov 13, 2026
| Company | Shares | Value as reported | % of company | % of portfolio | Change | As of |
|---|---|---|---|---|---|---|
| LB Pharmaceuticals Inc NASDAQ:LBRX | 631K | US$24.2M | 16.2% | no change | Sep 30, 2026 | |
| MapLight Therapeutics, Inc. NASDAQ:MPLT | 2.3M | US$23.4M | 5.4% | 15.7% | +1.33M | Sep 30, 2026 |
| Obsidian Therapeutics, Inc. NASDAQ:OBX | 919K | US$12.6M | 1.5% | 8.4% | new | Sep 30, 2026 |
| Cybin, Inc. NEO:HELP | 987K | US$12.1M | 1.4% | 8.1% | no change | Sep 30, 2026 |
| Evommune, Inc. NYSE:EVMN | 1.44M | US$11.9M | 3.5% | 8.0% | no change | Sep 30, 2026 |
| Nuvation Bio Inc. NYSE:NUVB | 1.33M | US$7.43M | 0.38% | 5.0% | new | Sep 30, 2026 |
| Incyte Corporation NASDAQ:INCY | 53,742 | US$6.52M | 0.03% | 4.4% | no change | Sep 30, 2026 |
| BeOne Medicines Ltd. Class A SSE:688235 | 15,722 | US$5.75M | 3.8% | no change | Sep 30, 2026 | |
| Rhythm Pharmaceuticals, Inc. NASDAQ:RYTM | 49,120 | US$4.68M | 3.1% | no change | Sep 30, 2026 | |
| Procore Technologies, Inc. NYSE:PCOR | 88,832 | US$4.59M | 3.1% | +35,533 | Sep 30, 2026 | |
| Revolution Medicines, Inc. NASDAQ:RVMD | 19,253 | US$3.95M | <0.01% | 2.6% | no change | Sep 30, 2026 |
| Kymera Therapeutics, Inc. NASDAQ:KYMR | 30,875 | US$3.45M | 2.3% | no change | Sep 30, 2026 | |
| Madrigal Pharmaceuticals, Inc. NASDAQ:MDGL | 5,672 | US$2.86M | 0.02% | 1.9% | no change | Sep 30, 2026 |
| argenx SE EURONEXT:ARGX | 2,800 | US$2.68M | 1.8% | no change | Sep 30, 2026 | |
| TCGX Acquisition Corp. NASDAQ:TCGX | 200K | US$2.5M | 1.7% | new | Sep 30, 2026 | |
| Celcuity Inc. NASDAQ:CELC | 28,300 | US$2.25M | 1.5% | no change | Sep 30, 2026 | |
| ACADIA Pharmaceuticals Inc. NASDAQ:ACAD | 103K | US$2.08M | 0.06% | 1.4% | no change | Sep 30, 2026 |
| Braveheart Bio, Inc. NASDAQ:BRVE | 81,376 | US$1.64M | 0.09% | 1.1% | new | Sep 30, 2026 |
| Harmony Biosciences Holdings, Inc. NASDAQ:HRMY | 27,049 | US$1.06M | 0.05% | 0.71% | no change | Sep 30, 2026 |
| iShares Bitcoin Trust ETF NASDAQ:IBIT | 15,968 | US$756K | <0.01% | 0.51% | new | Sep 30, 2026 |
| Insmed Incorporated NASDAQ:INSM | 6,580 | US$751K | <0.01% | 0.50% | no change | Sep 30, 2026 |
| Recursion Pharmaceuticals, Inc. NASDAQ:RXRX | 182K | US$750K | 0.03% | 0.50% | −414K | Sep 30, 2026 |
| Rani Therapeutics Holdings, Inc. NASDAQ:RANI | 494K | US$390K | 0.43% | 0.26% | no change | Sep 30, 2026 |
| Entrada Therapeutics, Inc. NASDAQ:TRDA | 49,082 | US$312K | 0.13% | 0.21% | no change | Sep 30, 2026 |
| Bolt Biotherapeutics, Inc. NASDAQ:BOLT | 5,000 | US$18,400 | 0.19% | 0.01% | no change | Sep 30, 2026 |